Health equity for older adults with cancer

RD Tucker-Seeley, SF Wallington, B Canin… - Journal of Clinical …, 2021 - ascopubs.org
The number of adults age 65 and older in the United States is expected to increase from
approximately 52 million in 2018 to 95 million in 2060, 1 with women representing …

Mapping the function of MicroRNAs as a critical regulator of tumor-immune cell communication in breast cancer and potential treatment strategies

AS Abdul Manap, AA Wisham, FW Wong… - Frontiers in Cell and …, 2024 - frontiersin.org
Among women, breast cancer ranks as the most prevalent form of cancer, and the presence
of metastases significantly reduces prognosis and diminishes overall survival rates. Gaining …

Trends in surgical axillary management in early stage breast cancer in elderly women: continued over-treatment

RJ Louie, CE Gaber, PD Strassle, KK Gallagher… - Annals of surgical …, 2020 - Springer
Introduction In the past two decades, three prospective randomized trials demonstrated that
elderly women with early stage hormone positive breast cancer had equivalent disease …

[HTML][HTML] Anlotinib inhibits the proliferation, migration and invasion, and induces apoptosis of breast cancer cells by downregulating TFAP2C

F Fang, Q Yuan - Oncology Letters, 2022 - spandidos-publications.com
The vascular endothelial growth factor receptor (VEGFR) network contributes to breast
cancer pathogenesis and progression. Anlotinib is a highly potent multi‑target tyrosine …

Survival among patients with untreated metastatic breast cancer: “What if I do nothing?

JK Plichta, SM Thomas, X Wang, SGR McDuff… - Breast Cancer Research …, 2024 - Springer
Purpose We sought to assess survival outcomes of patients with de novo metastatic breast
cancer (dnMBC) who did not receive treatment irrespective of the reason. Methods Adults …

[HTML][HTML] Clinicopathologic features, genomic profiles and outcomes of younger vs. older Chinese hormone receptor-positive (HR+)/HER2-negative (HER2-) metastatic …

J Wang, Y Liu, Y Liang, Y Zhang, H Dong… - Frontiers in …, 2023 - frontiersin.org
Background. Poor outcomes have been widely reported for younger vs. older breast cancer
patients, but whether this is due to age itself or the enrichment of aggressive clinical features …

[HTML][HTML] Identification of age differences in cancer-related symptoms in women undergoing chemotherapy for breast cancer in China

T Cai, T Zhou, J Chen, Q Huang, C Yuan, F Wu - BMC Women's Health, 2023 - Springer
Background Both contextual and cancer-related factors could be identified as causes of the
interindividual variability observed for symptoms experienced during breast cancer …

Comparisons of breast conserving therapy versus mastectomy in young and old women with early-stage breast cancer: long-term results using propensity score …

L Wang, Y He, J Li, T Wang, Y Xie, Z Fan… - Breast Cancer Research …, 2020 - Springer
Purpose This study aimed to compare the effect of BCT versus mastectomy on the
recurrence and survival of different-aged patients, and to investigate whether effects of BCT …

Unmet Social Needs and Breast Cancer Screening Utilization and Stage at Presentation

N Goel, M Lubarsky, AE Hernandez, K Benck… - JAMA Network …, 2024 - jamanetwork.com
Importance Unmet social needs in local populations may hinder the development of targeted
cancer control interventions aimed at improving screening utilization and early-stage breast …

Neoadjuvant chemotherapy for breast cancer in the elderly: are we accomplishing our treatment goals?

AD Williams, CT Dang, V Sevilimedu, M Morrow… - Annals of surgical …, 2022 - Springer
Introduction Rates of downstaging and tolerability to NAC in women age≥ 70 years with
operable breast cancer have not been well studied. We sought to compare downstaging …